Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-002284
Filing Date
2025-01-06
Accepted
2025-01-06 17:07:56
Documents
2
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1610
2 EX-24 kpti-ex24.htm EX-24 8313
  Complete submission text file 0000950170-25-002284.txt   11338
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address
Macomber Lori (Reporting) CIK: 0001968671 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 25512232